Adjuvant treatment for high-risk salivary gland malignancies and prognostic stratification based on a 20-year single institution experience.
Adjuvant treatment for high-risk salivary gland malignancies and prognostic stratification based on a 20-year single institution experience. Health Sci Rep. 2020 Dec; 3(4):e195.